NewsBenzingaHumana重申FY26调整后每股收益指引至少为9美元；在2027年医保优势计划星级评级中达成超越目标的第一四分位结果；预计2028年将受益于一次性投资并向股东回报 Humana重申FY26调整后每股收益指引至少为9美元；在2027年医保优势计划星级评级中达成超越目标的第一四分位结果；预计2028年将受益于一次性投资并向股东回报 Benzinga 2026.10.09 10:11 (GMT+0) Open on Benzinga Other news Wedbush Reiterates Outperform on Cognizant Tech Solns, Maintains $70 Price Target Fifth Third Bancorp Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $337 This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Oppenheimer Upgrades Fastly to Outperform, Announces $35 Price Target Tesla China-Made EV Sales Rise 5% in September, Extending Growth Streak To 11 Months Despite Global Sales Slump
Fifth Third Bancorp Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Tesla China-Made EV Sales Rise 5% in September, Extending Growth Streak To 11 Months Despite Global Sales Slump
